These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 24722295)
1. Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer. Dai Y; Wilson G; Huang B; Peng M; Teng G; Zhang D; Zhang R; Ebert MP; Chen J; Wong BC; Chan KW; George J; Qiao L Cell Death Dis; 2014 Apr; 5(4):e1170. PubMed ID: 24722295 [TBL] [Abstract][Full Text] [Related]
2. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway. Sun HW; Wu C; Tan HY; Wang QS Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917 [TBL] [Abstract][Full Text] [Related]
3. Suppression of tongue squamous cell carcinoma growth by inhibition of Jagged1 in vitro and in vivo. Zhang TH; Liu HC; Liang YJ; Liang LZ; Zheng GS; Huang HZ; Wu JN; Liao GQ J Oral Pathol Med; 2013 Apr; 42(4):322-31. PubMed ID: 23157415 [TBL] [Abstract][Full Text] [Related]
4. Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer. Steg AD; Katre AA; Goodman B; Han HD; Nick AM; Stone RL; Coleman RL; Alvarez RD; Lopez-Berestein G; Sood AK; Landen CN Clin Cancer Res; 2011 Sep; 17(17):5674-85. PubMed ID: 21753153 [TBL] [Abstract][Full Text] [Related]
5. Jagged1 expression regulated by Notch3 and Wnt/β-catenin signaling pathways in ovarian cancer. Chen X; Stoeck A; Lee SJ; Shih IeM; Wang MM; Wang TL Oncotarget; 2010 Jul; 1(3):210-8. PubMed ID: 20953350 [TBL] [Abstract][Full Text] [Related]
6. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Rodilla V; Villanueva A; Obrador-Hevia A; Robert-Moreno A; Fernández-Majada V; Grilli A; López-Bigas N; Bellora N; Albà MM; Torres F; Duñach M; Sanjuan X; Gonzalez S; Gridley T; Capella G; Bigas A; Espinosa L Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6315-20. PubMed ID: 19325125 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters. Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415 [TBL] [Abstract][Full Text] [Related]
8. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291 [TBL] [Abstract][Full Text] [Related]
9. Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. Lu J; Ye X; Fan F; Xia L; Bhattacharya R; Bellister S; Tozzi F; Sceusi E; Zhou Y; Tachibana I; Maru DM; Hawke DH; Rak J; Mani SA; Zweidler-McKay P; Ellis LM Cancer Cell; 2013 Feb; 23(2):171-85. PubMed ID: 23375636 [TBL] [Abstract][Full Text] [Related]
10. Stroma-induced Jagged1 expression drives PC3 prostate cancer cell migration; disparate effects of RIP-generated proteolytic fragments on cell behaviour and Notch signaling. Delury C; Hart C; Brown M; Clarke N; Parkin E Biochem Biophys Res Commun; 2016 Mar; 472(1):255-61. PubMed ID: 26921446 [TBL] [Abstract][Full Text] [Related]
11. Regulation of vascular smooth muscle cell phenotype in three-dimensional coculture system by Jagged1-selective Notch3 signaling. Bhattacharyya A; Lin S; Sandig M; Mequanint K Tissue Eng Part A; 2014 Apr; 20(7-8):1175-87. PubMed ID: 24138322 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of Jagged1 expression in human and mouse intestinal tumors: implications for targeting Notch signaling. Guilmeau S; Flandez M; Mariadason JM; Augenlicht LH Oncogene; 2010 Feb; 29(7):992-1002. PubMed ID: 19935714 [TBL] [Abstract][Full Text] [Related]
13. The wnt target jagged-1 mediates the activation of notch signaling by progastrin in human colorectal cancer cells. Pannequin J; Bonnans C; Delaunay N; Ryan J; Bourgaux JF; Joubert D; Hollande F Cancer Res; 2009 Aug; 69(15):6065-73. PubMed ID: 19622776 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer. Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977 [TBL] [Abstract][Full Text] [Related]
15. Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells. Yamamoto S; Tateishi K; Kudo Y; Yamamoto K; Isagawa T; Nagae G; Nakatsuka T; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Aburatani H; Omata M; Koike K Carcinogenesis; 2013 Oct; 34(10):2380-8. PubMed ID: 23698634 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. Du R; Sun W; Xia L; Zhao A; Yu Y; Zhao L; Wang H; Huang C; Sun S PLoS One; 2012; 7(2):e30771. PubMed ID: 22363487 [TBL] [Abstract][Full Text] [Related]
17. Control of Notch-ligand endocytosis by ligand-receptor interaction. Hansson EM; Lanner F; Das D; Mutvei A; Marklund U; Ericson J; Farnebo F; Stumm G; Stenmark H; Andersson ER; Lendahl U J Cell Sci; 2010 Sep; 123(Pt 17):2931-42. PubMed ID: 20720151 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Pang RT; Leung CO; Ye TM; Liu W; Chiu PC; Lam KK; Lee KF; Yeung WS Carcinogenesis; 2010 Jun; 31(6):1037-44. PubMed ID: 20351093 [TBL] [Abstract][Full Text] [Related]
19. Jagged1 regulates the activation of astrocytes via modulation of NFkappaB and JAK/STAT/SOCS pathways. Morga E; Mouad-Amazzal L; Felten P; Heurtaux T; Moro M; Michelucci A; Gabel S; Grandbarbe L; Heuschling P Glia; 2009 Dec; 57(16):1741-53. PubMed ID: 19455581 [TBL] [Abstract][Full Text] [Related]
20. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells. Lu J; Zhang L; Zhou H; Du Z; Zhang G Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]